Viracta Therapeutics Inc. buy melinda
Start price
30.09.13
/
50%
€767.97
Target price
31.03.14
€945.00
Performance (%)
24.17%
End price
31.03.14
€953.61
Summary
This prediction ended on 31.03.14 with a price of €953.61. The prediction had a final performance of 24.17%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Viracta Therapeutics Inc. | -5.333% | -5.333% | -31.068% | -88.685% |
iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
Comments by melinda for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Laufzeit überschritten)
Stopped prediction by melinda for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.13
27.09.20
27.09.20
€8.75
04.11.21
04.11.21
28.57%
05.11.21
05.11.21
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€52.50
04.04.19
04.04.19
€70.00
30.10.19
30.10.19
-63.33%
30.10.19
30.10.19
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.08
17.03.19
17.03.19
€52.50
04.04.19
04.04.19
102.68%
04.04.19
04.04.19
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€126.28
13.03.18
13.03.18
€232.04
13.09.18
13.09.18
-49.75%
13.09.18
13.09.18